Therapy for peripheral T-cell lymphomas: Where we are and where we hope to be

Neha Mehta-Shah; Steven Horwitz

Therapy for peripheral T-cell lymphomas: Where we are and where we hope to be

Research output: Contribution to journal › Article › peer-review

Abstract

Our standard therapies for peripheral T-cell lymphoma may cure a subset of patients, and thus far novel agents have not changed the outcomes for the majority.

Original language	English
Journal	ONCOLOGY (United States)
Volume	29
Issue number	8
State	Published - Aug 15 2015

Cite this

@article{4ed0e55778ef4225868b8405d551ef6f,

title = "Therapy for peripheral T-cell lymphomas: Where we are and where we hope to be",

abstract = "Our standard therapies for peripheral T-cell lymphoma may cure a subset of patients, and thus far novel agents have not changed the outcomes for the majority.",

author = "Neha Mehta-Shah and Steven Horwitz",

year = "2015",

month = aug,

day = "15",

language = "English",

volume = "29",

journal = "ONCOLOGY (United States)",

issn = "0890-9091",

number = "8",

}

TY - JOUR

T1 - Therapy for peripheral T-cell lymphomas

T2 - Where we are and where we hope to be

AU - Mehta-Shah, Neha

AU - Horwitz, Steven

PY - 2015/8/15

Y1 - 2015/8/15

N2 - Our standard therapies for peripheral T-cell lymphoma may cure a subset of patients, and thus far novel agents have not changed the outcomes for the majority.

AB - Our standard therapies for peripheral T-cell lymphoma may cure a subset of patients, and thus far novel agents have not changed the outcomes for the majority.

UR - http://www.scopus.com/inward/record.url?scp=84939533834&partnerID=8YFLogxK

M3 - Article

C2 - 26281839

AN - SCOPUS:84939533834

SN - 0890-9091

VL - 29

JO - ONCOLOGY (United States)

JF - ONCOLOGY (United States)

IS - 8

ER -

Therapy for peripheral T-cell lymphomas: Where we are and where we hope to be

Abstract

Other files and links

Fingerprint

Cite this